Product
Cadonilimab Lenvatinib
1 clinical trial
1 indication
Indication
CadonilimabClinical trial
A Phase II, Single-arm, Multicenter, Prospective Study of Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2025-01-01